
- /
- Supported exchanges
- / US
- / TRML.NASDAQ
Tourmaline Bio Inc. (TRML NASDAQ) stock market data APIs
Tourmaline Bio Inc. Financial Data Overview
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tourmaline Bio Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Tourmaline Bio Inc. data using free add-ons & libraries
Get Tourmaline Bio Inc. Fundamental Data
Tourmaline Bio Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -102 406 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: -0.91
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tourmaline Bio Inc. News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, WOW, TRML, BTBD on Behalf of Shareholders
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or br...


BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paramount Group, Inc. (NYSE – PGRE), Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW)
BALA CYNWYD, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky...

Notable healthcare headlines for the week: Novo Nordisk, Novartis and UnitedHealth in focus
Wall Street's major averages closed mixed on Friday, with the Nasdaq Composite (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) closing at new highs every day of the week, while the Dow (DJI [htt...

Top global stories this week: Anglo-Teck, Taiwan Semiconductor among notable names
[Businesspeople walking across painted world map, carrying moving boxes] Klaus Vedfelt/DigitalVision via Getty Images Most major stock indexes across the globe ended the week higher, tracking gains...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.